IceCure Medical (ICCM) Operating Expenses (2020 - 2026)

IceCure Medical (ICCM) has reported Operating Expenses for 7 consecutive years, with $3.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Expenses rose 21.36% year-over-year to $3.2 million in Q2 2026; TTM through Jun 2026 was $13.4 million, a 25.23% increase from a year earlier, with the FY2025 full-year figure at $12.2 million, up 10.36% from the prior year.
• Operating Expenses was $3.2 million for Q2 2026 at IceCure Medical, down from $3.5 million in the prior quarter.
• Over five years, Operating Expenses peaked at $4.1 million in Q1 2022 and troughed at $2.5 million in Q2 2024.
• A 5-year average of $3.2 million and a median of $3.2 million in 2023 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses soared 124.21% in 2022 and dropped 25.08% in 2024, its largest moves.
• Over 5 years, Operating Expenses stood at $3.4 million in 2022, then declined by 18.85% to $2.8 million in 2023, then decreased by 3.38% to $2.7 million in 2024, then surged by 30.96% to $3.5 million in 2025, then retreated by 8.3% to $3.2 million in 2026.
• The last three Operating Expenses figures came in at $3.2 million (Q2 2026), $3.5 million (Q1 2026), and $3.5 million (Q4 2025), per Business Quant data.